Home » Newsletters » BioWorld Science

BioWorld Science

March 26, 1997

View Archived Issues

Sankyo prepares ACAT inhibitors

Sumitomo reveals antipsychotic agents with reduced side effects

Taiho discloses antiangiogenic agents

Hypoglycemic/hypolipidemic agents from Kyorin

Novel antibiotic isolated by Kitasato Institute and Chinese Academy of Medical Science

Kitasato Institute discovers inhibitor of IL-6 activity

Cysteine protease inhibitors described by Senju

Novel recombinant protein for bone diseases from Hoechst

Fujisawa obtains natural antifungal agent

PGD2 antagonists claimed by Shionogi

Research on cardiovascular drugs reported at the meeting of the Japanese Circulation Society

Antidepressant effects of NKH-477

ME-3167 heading for NDA submission

Meiji Seika antibiotic scheduled for launch in Europe in 1998

Novel antipsychotic agent reported by Asahi Chemical

DepoTech's new formulation of morphine sulfate enters phase I

Cor Therapeutics receives nonapprovable letter for Integrilin NDA

Cubist Pharmaceuticals and Genzyme enter compound library screening collaboration

Aphton issued U.S. patents covering Gastrimmune

Synsorb Cd enters phase II

Cangene signs distribution agreement for WinRho SDF

Biogen licenses Hirulog

Luvox cleared for OCD in children and adolescents

Axcan receives approvable letter for URSO from FDA

U.S. patent covers Connetics TCR vaccine technology

Biological role of CD39 uncovered by Immunex and collaborators

Subcutaneous IL-2 boosts CD4 cell counts in HIV-infected patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...